🔎 Trials Near Me

Почетна › Трипл негативен рак на дојка › Флорида

Клинички испитувања за Трипл негативен рак на дојка во Флорида

47 студии за Трипл негативен рак на дојка бараат учесници на локации во Флорида.

Градови во Флорида

Официјален текст на студијата (англиски)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of Miami - Sylvester Comprehensive Cancer Center, Miami
  • Advent Health, Orlando
  • Florida Cancer Specialists South, Port Charlotte
Се регрутираФаза 1/2
Возраст 12 и постари · Сите полови · Ажурирано 2.10.2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  • AdventHealth Cancer Institute, Orlando
Се регрутираФаза 1
Возраст 19 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06586957

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

  • Florida Cancer Specialists, Sarasota
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT06799065

Study of AVZO-021 in Patients With Advanced Solid Tumors

  • Avenzo Therapeutics Recruiting Site, Sarasota
  • Avenzo Therapeutics Recruiting Site, Tampa
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT05867251

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

  • Baptist MD Anderson Cancer Center, Jacksonville
Се регрутира
Возраст 30 и постари · Жени · Ажурирано 25.9.2026 · NCT02945579

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

  • AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0044), Altamonte Springs
  • Florida Cancer Specialists - South ( Site 7004), Fort Myers
  • Bioresearch Partner ( Site 0072), Hialeah
  • и уште 2
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06966700

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • Mayo Clinic Jacksonville, Jacksonville
  • Moffitt Cancer Center, Tampa
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT04981119

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

  • AdventHealth Altamonte Springs ( Site 0125), Altamonte Springs
  • Orlando Health Cancer Institute ( Site 0030), Orlando
  • Comprehensive Hematology Oncology ( Site 0091), St. Petersburg
  • и уште 1
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06393374

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

  • AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0007), Altamonte Springs
  • Orlando Health Cancer Institute ( Site 0012), Orlando
  • Florida Cancer Specialists - East ( Site 7000), West Palm Beach
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06841354

Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer

  • Morton Plant Hospital - Baycare Health System, Clearwater
  • Moffitt Cancer Center, Tampa
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT05528133

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

  • University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT06618287

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Sylvester Comprehensive Cancer Center, Miami
  • Sara Cannon Research Institute Lake Nona, Orlando
  • Hematology - Oncology Associates of the Treasure Coast, Port Saint Lucie
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 21.9.2026 · NCT05983432

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

  • Biogenix Molecular, LLC, Miami
  • Advent Health Medical Group Radiation Oncology at Central Florida, Orlando
  • Moffitt Cancer Center, Tampa
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 17.9.2026 · NCT07020117

Study of Screening Brain MRIs in Stage IV Breast Cancer

  • Morton Plant Mease- Baycare, Clearwater
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 15.9.2026 · NCT05115474

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

  • University of Miami, Miami
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 11.9.2026 · NCT06657222

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

  • Mayo Clinic Florida, Jacksonville
  • Cancer Specialists of North Florida, Jacksonville
  • Jupiter Medical Center, Jupiter
  • и уште 4
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT05633654

Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

  • UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
  • и уште 7
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT03606967

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

  • BAPTIST ALLIANCE - MCI (Data Collection Only), Miami
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT05570253

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

  • Cleveland Clinic Florida, Weston
Се регрутираНабљудувачка студија
Возраст од 18 до 99 · Сите полови · Ажурирано 3.9.2026 · NCT07211178

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

  • SCRI Florida Cancer Specialists - Sarasota, Sarasota
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 28.8.2026 · NCT07029399

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

  • Mayo Clinic in Florida, Jacksonville
Се регрутираФаза 1/2
Возраст 16 и постари · Сите полови · Ажурирано 20.8.2026 · NCT05269381

SMP-3124LP in Adults With Advanced Solid Tumors

  • Advent Health, Celebration
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 12.8.2026 · NCT06526819

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

  • Local Institution - 0296, Pembroke Pines
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 10.8.2026 · NCT06926868

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

  • Miami Baptist Cancer Institute/, Miami
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 6.8.2026 · NCT06176261

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • USOR Florida Cancer Specialists South, Fort Myers
  • USOR Florida Cancer Specialists North, St. Petersburg
  • USOR Florida Cancer Specialists East, West Palm Beach
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 4.8.2026 · NCT05579366

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

  • Mayo Clinic Jacksonville, Jacksonville
Се регрутираФаза 1
Возраст од 18 до 100 · Сите полови · Ажурирано 29.7.2026 · NCT06562192

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

  • Florida Cancer Specialists - Lake Nona, Orlando
  • Florida Cancer Specialists - Sarasota, Sarasota
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 28.7.2026 · NCT06150664

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

  • Mayo Clinic - Jacksonville, Jacksonville
  • Florida Cancer Specialists, Sarasota
  • Moffitt Cancer Center, Tampa
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 29.6.2026 · NCT05377996

A Study of LY4175408 in Participants With Advanced Cancer

  • Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando
  • Florida Cancer Specialists - Sarasota, Sarasota
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 23.6.2026 · NCT07046923

Study of XB010 in Subjects With Solid Tumors

  • Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 22.6.2026 · NCT06545331

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

  • Florida Cancer Specialists, Sarasota
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 18.6.2026 · NCT07503808

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

  • University of Miami Health System, Coral Gables
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 15.6.2026 · NCT05768932

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

  • Moffitt Cancer Center, Tampa
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 11.6.2026 · NCT05076760

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

  • Moffitt Cancer Center and Research Institute, Tampa
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 4.6.2026 · NCT04300556

Phase 1 Study of CLR 125 in Triple Negative Breast Cancer

  • Mayo Clinic Florida, Jacksonville
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 3.6.2026 · NCT07311993

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

  • H. Lee Moffitt Cancer Center and Research Institute, Tampa
  • Moffitt Cancer Center, Tampa
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 6.5.2026 · NCT01042379

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

  • Miami Cancer Institute at Baptist Health (Kendall), Miami
  • Miami Cancer Institute at Baptist Health, Plantation
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 29.4.2026 · NCT04468061

Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy

  • Moffitt Cancer Center, Tampa
Се регрутираРана фаза 1
Возраст 18 и постари · Сите полови · Ажурирано 1.4.2026 · NCT06435351

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

  • Baptist Alliance - McI, Miami
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 27.2.2026 · NCT03808337

DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer

  • Moffitt Cancer Center, Tampa
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 5.2.2026 · NCT05504707

Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.